lu 135252 has been researched along with Pulmonary Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderone, A; Colombo, F; Dupuis, J; Nguyen, QT; Rouleau, JL | 1 |
1 other study(ies) available for lu 135252 and Pulmonary Fibrosis
| Article | Year |
|---|---|
LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction.
Topics: Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Hemodynamics; Male; Myocardial Infarction; Phenotype; Phenylpropionates; Pulmonary Artery; Pulmonary Fibrosis; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A | 2000 |